Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective Alternative to PSA Screening and Standard Biopsy

AJR Am J Roentgenol. 2023 Sep;221(3):389. doi: 10.2214/AJR.23.29011. Epub 2023 Jan 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biopsy
  • Cost-Benefit Analysis
  • Early Detection of Cancer / methods
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / pathology

Substances

  • Prostate-Specific Antigen